| Advanced Biomed Inc. (ADVB) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 | |
| Balance Sheet Date | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | |||||||||||||||||||||||||||||||||||||||||||||
| Fiscal Period | Q1-FY2026 | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | |||||||||||||||||||||||||||||||||||||||||||||
| Operating Cash Flow | (610,342$) | (1,543,962$) | (3,409,572$) | (29,680$) | (475,828$) | (1,065,658$) | |||||||||||||||||||||||||||||||||||||||||||
| Investing Cash Flow | (1,771$) | (20,149$) | (2,215$) | (19,978$) | (53,256$) | 26,699$ | |||||||||||||||||||||||||||||||||||||||||||
| Purchases of Property and Equipment | 1,771$ | 20,149$ | 2,215$ | 19,978$ | 53,256$ | (26,699$) | |||||||||||||||||||||||||||||||||||||||||||
| Financing Cash Flow | 447,462$ | (765,466$) | 5,898,956$ | 392,525$ | 323,536$ | 562,199$ | |||||||||||||||||||||||||||||||||||||||||||
| End Cash Position | 2,656,519$ | 2,903,915$ | 5,184,100$ | 2,657,235$ | 2,646,992$ | 2,607,973$ | 2,663,704$ | 2,776,622$ | |||||||||||||||||||||||||||||||||||||||||
| Exchange Rate Effect | (82,745$) | 49,392$ | 39,696$ | (303,848$) | 149,817$ | 363,842$ | |||||||||||||||||||||||||||||||||||||||||||
| Dividends Paid | |||||||||||||||||||||||||||||||||||||||||||||||||
| Unlevered Free Cash Flow | (612,113$) | (1,564,111$) | (3,411,787$) | (49,658$) | (529,084$) | (1,038,959$) | |||||||||||||||||||||||||||||||||||||||||||